Wall Street Already Has 10 Leveraged Anthropic ETFs Lined Up, and Half Bet Against It
Five issuers have already filed fee tables for funds that amplify a stock nobody can buy yet. Why the rush to claim a ticker, and what quietly eats away at traders who hold these funds past a few days?
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Anthropic’s stock hasn’t been listed yet, but investors can already review the fee tables for funds built to amplify it. As of November 6, 2026, five issuers have SEC prospectuses on file for at least 10 leveraged ETFs tied to Anthropic, the maker of the Claude chatbot.
Anthropic filed its S-1 publicly on October 26 and amended it on November 2. It plans to list Class A shares on the Nasdaq Global Select Market under the symbol ANT, but it has not set a price range or a date.
Each issuer pairs a fund seeking 2x the stock’s daily move with one seeking -2x, so half of the ten rise when Anthropic falls. That split reflects product design: issuers sell both directions to capture traders on either side, so the inverse funds reflect demand from traders on both sides rather than a forecast.
Timing remains uncertain because prediction-market odds of a listing before December 1 fell from about 80% to near 50% as AI stocks sold off, and none of these funds can trade until ANT does.
Who Has Filed and What Each Fund Costs
| Issuer | Exchange | Expense Ratio |
|---|---|---|
| ProShares | Nasdaq | 0.95% net, 1.04% gross |
| Defiance | Nasdaq | 0.71% (long) |
| GraniteShares | Nasdaq | 1.33% (long) |
| Direxion | Nasdaq | 0.97% net (bull) |
| Leverage Shares | Cboe BZX | 0.75% |
Direxion first filed its pair on NYSE Arca on October 27, then moved it to Nasdaq in an October 28 revision. Leverage Shares also filed a 1x short fund at 0.99%.
Other issuers have also filed. Tradr pushed its pair’s effective date to November 12, REX has a pair in a November 4 filing that is not yet effective, and YieldMax filed an option income fund.
Why Funds Exist Before the Stock Does
The first fund to list in a hot single-stock segment usually collects most of the assets, and assets generate fee income. Filing early gets a ticker and a place in line.
An effective prospectus only passes paperwork. ProShares’ funds became effective November 6, yet its fund page says neither has launched, and Direxion’s funds list only when operations begin.
Inverse funds matter for early trading because borrowable shares of a fresh IPO are scarce. A -2x fund gives bears an easy short, which could add selling pressure in ANT’s first weeks.
How Daily Resets Erode Returns
These funds reset leverage daily, so returns over weeks can differ sharply from twice the stock’s move. After a down day, gains compound from a smaller base, so a rebound has to work harder.
At 90% volatility, the Defiance long fund would be expected to lose 76% over a year even if the stock ended flat. Choppy trading hurts long and inverse funds alike.
A stock with no trading history will likely swing hard, which makes decay more relevant. Fees matter little for a two-day trade but add up for anyone holding for months.
There are also other risks.
A delayed IPO leaves these funds idle. Anthropic had been targeting the week before Thanksgiving and could raise up to $100 billion, with unnamed sources discussing a valuation of $1 trillion to $1.3 trillion. First-day spreads may be wide and tracking loose, and leverage amplifies both an IPO pop and a post-IPO decline.
How Leveraged Anthropic ETFs Fit Different Investors
Active traders have a real bull case here. If ANT trends hard after listing, a 2x fund held for days can double a strong move, and inverse funds offer a cleaner short than borrowing new shares.
The risks outweigh that case because volatility will likely peak exactly when these funds launch, and decay hurts anyone who holds.
For retirement accounts, the daily reset makes these funds a poor match for long holding periods, while plain ANT shares carry no leverage and no daily reset.
The trigger to check is an amended S-1 with a price range. Until that filing appears, none of these funds can trade.
Contact [email protected] for any questions or corrections.
Omor Ibne Ehsan is a writer at 24/7 Wall St. He is a self-taught investor with a focus on growth, cyclical, and dividend equities that have strong fundamentals, value, and long-term potential. He also has an interest in high-risk, high-reward investments such as penny stocks.
